Literature DB >> 4018929

Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man.

E Puigdellívol, M E Carral, J Moreno, J M Plà-Delfina, F Jané.   

Abstract

The bioavailability of tranexamic acid after the administration of a single intramuscular dose was estimated in three healthy male volunteers. 500 mg tranexamic acid were given intramuscularly and intravenously, as a bolus injection, to each subject on separate occasions. Following intramuscular administration, the peak plasma concentrations were attained after approximately one hour and the apparent elimination half-life was about two hours. The absolute bioavailability was 105.2 +/- 10.7% (mean +/- SD). At the dose given, the bioavailability of tranexamic acid after intramuscular administration is fast and complete.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018929

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  9 in total

1.  Topical tranexamic Acid does not affect electrophysiologic or neurovascular sciatic nerve markers in an animal model.

Authors:  Ran Schwarzkopf; Phuc Dang; Michele Luu; Tahseen Mozaffar; Ranjan Gupta
Journal:  Clin Orthop Relat Res       Date:  2015-01-06       Impact factor: 4.176

2.  Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.

Authors:  Susan M Goobie; Petra M Meier; Navil F Sethna; Sulpicio G Soriano; David Zurakowski; Snehal Samant; Luis M Pereira
Journal:  Clin Pharmacokinet       Date:  2013-04       Impact factor: 6.447

Review 3.  Tranexamic acid: a review of its use in the management of menorrhagia.

Authors:  Keri Wellington; Antona J Wagstaff
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.

Authors:  Ian Roberts; Haleema Shakur-Still; Amy Aeron-Thomas; Danielle Beaumont; Antonio Belli; Amy Brenner; Madeleine Cargill; Rizwana Chaudhri; Nicolas Douglas; Lauren Frimley; Catherine Gilliam; Amber Geer; Zahra Jamal; Rashid Jooma; Raoul Mansukhani; Alec Miners; Jason Pott; Danielle Prowse; Temitayo Shokunbi; Jack Williams
Journal:  Health Technol Assess       Date:  2021-04       Impact factor: 4.014

5.  The efficacy and safety of tranexamic acid in reducing perioperative blood loss in patients with multilevel thoracic spinal stenosis: A retrospective observational study.

Authors:  Peng Xue; Junsong Yang; Xiaozhou Xu; Tuanjiang Liu; Yansheng Huang; Feng Qiao; Xiaoqiang Huang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

6.  Serum Concentrations and Pharmacokinetics of Tranexamic Acid after Two Means of Topical Administration in Massive Weight Loss Skin-Reducing Surgery.

Authors:  Kjersti Ausen; Hilde Pleym; Jiayin Liu; Solfrid Hegstad; Håvard Bersås Nordgård; Ivan Pavlovic; Olav Spigset
Journal:  Plast Reconstr Surg       Date:  2019-06       Impact factor: 4.730

7.  Intramuscular uptake of tranexamic acid during haemorrhagic shock in a swine model.

Authors:  Håkon Kvåle Bakke; Ole Martin Fuskevåg; Erik Waage Nielsen; Erik Sveberg Dietrichs
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-12-18       Impact factor: 2.953

8.  Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers.

Authors:  Zoe Kane; Roberto Picetti; Alison Wilby; Joseph F Standing; Stanislas Grassin-Delyle; Ian Roberts; Haleema Shakur-Still
Journal:  Eur J Pharm Sci       Date:  2021-06-01       Impact factor: 4.384

9.  WOMAN-PharmacoTXA trial: Study protocol for a randomised controlled trial to assess the pharmacokinetics and pharmacodynamics of intramuscular, intravenous and oral administration of tranexamic acid in women giving birth by caesarean section.

Authors:  Monica Arribas; Ian Roberts; Rizwana Chaudhri; Amber Geer; Danielle Prowse; Mwansa Ketty Lubeya; Aasia Kayani; Kiran Javaid; Stanislas Grassin-Delyle; Haleema Shakur-Still
Journal:  Wellcome Open Res       Date:  2021-06-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.